Key result
Recombinant human Periostin promoted migration and osteogenic differentiation of periodontal ligament mesenchymal stem cells under inflammatory conditions via the JNK pathway.
Why the study?
Does Periostin (POSTN) promote migration and osteogenic differentiation of human periodontal ligament mesenchymal stem cells under inflammatory conditions?
Does Periostin (POSTN) promote migration and osteogenic differentiation of human periodontal ligament mesenchymal stem cells under inflammatory conditions?
Periostin promotes the migration and osteogenic differentiation of periodontal ligament mesenchymal stem cells under inflammatory conditions via the JNK pathway, suggesting a potential target for periodontal tissue regeneration.
Periostin effects on PDL stem cells remain preclinical; leaves open translation to regenerative therapies pending in vivo validation.
OBJECTIVES: Mesenchymal stem cell (MSC)-mediated periodontal tissue regeneration is considered to be a promising method for periodontitis treatment. The molecular mechanism of functional regulation by MSCs remains unclear, thus limiting their application. Our previous study discovered that Periostin (POSTN) promoted the migration and osteogenic differentiation of periodontal ligament mesenchymal stem cells (PDLSCs), but it is still unclear whether POSTN is able to restore the regenerative potential of PDLSCs under inflammatory conditions. In this study, we investigated the effect of POSTN on PDLSCs under inflammatory conditions and its mechanism. MATERIALS AND METHODS: PDLSCs were isolated from periodontal ligament tissue. TNF-α was used at 10 ng/mL to mimic inflammatory conditions. Lentivirus POSTN shRNA was used to knock down POSTN. Recombinant human POSTN (rhPOSTN) was used to stimulate PDLSCs. A scratch assay was used to analyse cell migration. Alkaline phosphatase (ALP) activity, Alizarin Red staining and expression of osteogenesis-related genes were used to investigate the osteogenic differentiation potential. Western blot analysis was used to detect the mitogen-activated protein kinases (MAPK) and AKT signalling pathways. RESULTS: After a 10 ng/mL TNF-α treatment, knockdown of POSTN impeded scratch closure, inhibited ALP activity and mineralization in vitro, and decreased expression of RUNX2, OSX, OPN and OCN in PDLSCs, while 75 ng/mL rhPOSTN significantly accelerated scratch closure, enhanced ALP activity and mineralization in vitro, and increased expression of RUNX2, OSX, OPN and OCN. In addition, knockdown of POSTN inhibited expression of phosphorylated c-Jun N-terminal kinase (p-JNK), while 75 ng/mL rhPOSTN increased expression of p-JNK in PDLSCs with TNF-α treatment. Furthermore, inhibition of JNK by its inhibitor SP600125 dramatically blocked POSTN-enhanced scratch closure, ALP activity and mineralization in PDLSCs. CONCLUSIONS: Our results revealed that POSTN might promote the migration and osteogenic differentiation potential of PDLSCs via the JNK pathway, providing insight into the mechanism underlying MSC biology under inflammatory conditions and identifying a potential target for improving periodontal tissue regeneration.
No takes yet. Share an insight, caveat, or question.
Tang et al. (2017) studied Periodontitis. Periostin (POSTN) vs. POSTN knockdown (shRNA) / control was evaluated on Cell migration and osteogenic differentiation (ALP activity, mineralization, and expression of RUNX2, OSX, OPN, and OCN). Recombinant human Periostin promoted migration and osteogenic differentiation of periodontal ligament mesenchymal stem cells under inflammatory conditions via the JNK pathway.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: